On September 1, 2024, the "Forum on Implementing the Spirit of the 20th Central Committee and Exploring New Opportunities for Qingdao's Development" took place at the Qingdao International Conference Center.

List of Award-Winning Model Enterprises in Qingdao

The "2023 Qingdao Annual Economic Achievements Promotion Event" was guided by the Qingdao Municipal Publicity Department, Qingdao Federation of Industry and Commerce, Qingdao Municipal Bureau of Industry and Information Technology, Qingdao State-owned Assets Supervision and Administration Commission, and Qingdao Private Economic Development Bureau. It was jointly organized by the Qingdao Enterprise Confederation, Qingdao Entrepreneurs Association, Qingdao Industrial Economy Federation, Qingdao Daily, Qingdao Radio and Television Station, and Qingdao Publishing Group. The event aimed to fully showcase Qingdao's economic achievements in 2023, promote high-quality economic development, create a first-class business environment, and foster a societal atmosphere that respects and motivates entrepreneurs.

At the Consultation Meeting Venue

At the consultation meeting, Wang Tingwei stated that as a pharmaceutical innovation company rooted in Qingdao, Baheal Pharma Group has always adhered to technological innovation as its core driving force, continuously promoting the transformation of cutting-edge scientific research into real productivity and facilitating the aggregation of high-quality medical and health resources. With the thoughtful guidance and policy support from various levels of the Qingdao government, BAHEAL has diligently advanced the innovation, research and development, and production transformation of high-end medical devices, consistently injecting strong momentum into the development of Qingdao's health industry.

Currently, with national policies continuously encouraging technological innovation and accelerating the formation of new productive forces, BAHEAL, as an "industry investor," is focusing on three key value areas: innovative drugs, high-end medical devices, and basic research platforms. By partnering with national-level research institutions, BAHEAL aims to identify and cultivate medical innovation achievements with First-in-Class potential and breakthrough "bottleneck" technologies. Acting as a "catalyst" for medical innovation, BAHEAL stimulates innovative vitality, leverages industry resources, and employs advanced incubation mechanisms to continually advance projects with innovation and industrialization potential towards successful implementation.

BAHEAL has established industrial bases across three key locations: Beijing, Qingdao, and Langfang. Qingdao functions as the hub for high-end medical device manufacturing and pharmaceutical formulation R&D and production. The city is actively driving the large-scale production of innovative medical devices and building a comprehensive after-sales service center. Additionally, Qingdao BAHEAL Pharmaceutical, renowned for passing multiple FDA inspections with "zero defects," is advancing the large-scale production of cutting-edge innovative drugs in Qingdao. To further promote the development of Qingdao's health industry, BAHEAL has partnered with the Shibei District Government to jointly establish a large-scale health industry investment fund worth 1 billion yuan. Managed by BAHEAL Zhongxin Fund, this fund is focused on investing in and incubating truly innovative projects with clinical application value, aiming to cultivate more growth points and sources of vitality for Qingdao.

In the future, BAHEAL will unwaveringly uphold its core philosophy of technological innovation, dedicated to continuously innovating and optimizing medical scenarios. While driving its own steady and sustainable development, BAHEAL will also collaborate with industry partners to explore new paths of innovation, thus injecting sustained vitality and creativity into the high-quality economic and social development of Qingdao.